CVI
Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Schlenke, P.
Right arrow Articles by Bein, G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Schlenke, P.
Right arrow Articles by Bein, G.

Clinical and Diagnostic Laboratory Immunology, November 1998, p. 808-813, Vol. 5, No. 6
1071-412X/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.

Evaluation of a Novel Mononuclear Cell Isolation Procedure for Serological HLA Typing

Peter Schlenke,1,* Harald Klüter,1 Michael Müller-Steinhardt,1 Hans-Jörg Hammers,1 Kerstin Borchert,1 and Gregor Bein2

Institute of Immunology and Transfusion Medicine, University of Luebeck School of Medicine, D23538 Luebeck,1 and Institute of Clinical Immunology and Transfusion Medicine, University of Giessen, D35392 Giessen,2 Germany

Received 4 May 1998/Returned for modification 7 June 1998/Accepted 18 September 1998

Despite recent advances in DNA-based genotyping, the microcytotoxicity test is still broadly used for the determination of human leukocyte class I antigens in patients as well as organ donors and also for the detection of HLA antibodies. Excellent purity and viability of peripheral blood mononuclear cells (PBMC) are essential for reliable HLA typing results. Background staining and cell loss can contribute to impaired typing results or even cause misinterpretations. A novel isolation procedure using cell preparation tubes (CPT) with prefilled Ficoll was compared with the standard Ficoll gradient. We determined the recovery, purity, and viability of the PBMC after several periods of storage. Finally, the isolated cells were used for HLA class I typing, and background reactivities were scored. By using the CPT method, the recovery of PBMC was significantly higher than recovery with the standard technique (P <=  0.001). Contamination by granulocytes increased considerably during the storage time for the standard protocol, whereas purity remained stable when CPT were used (P <=  0.001). With both methods, lymphocyte viability declined markedly over time. We found significantly more dead cells by using the CPT methods. Due to high background scores, HLA typing was impossible after 48 h. The isolation of PBMC by the CPT method resulted in a higher yield and improved purity compared to those obtained with the standard gradient technique. The decreasing viability after 48 h limits the use of both methods for HLA typing and HLA antibody screening.


* Corresponding author. Mailing address: University of Luebeck, Institute of Immunology and Transfusion Medicine, Ratzeburger Allee 160, 23538 Luebeck, Germany. Phone: 49-451-5002841. Fax: 49-451-5002857. E-mail: schlenke{at}immu.mu-luebeck.de.


Clinical and Diagnostic Laboratory Immunology, November 1998, p. 808-813, Vol. 5, No. 6
1071-412X/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.



This article has been cited by other articles:




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
Antimicrob. Agents Chemother. Clin. Microbiol. Rev. Infect. Immun.
J. Clin. Microbiol. J. Virol. ALL ASM JOURNALS

Copyright © 1998 by the American Society for Microbiology. All rights reserved.